Menora Mivtachim Holdings’s Redhill Biopharma RDHL Stock Holding History

Menora Mivtachim Holdings’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-409	Closed	-$3.4M	–	81
2019 Q1	$3.4M	Sell	409 -12	-3%	-$94.9K	0.09%	65
2018 Q4	$2.34M	Hold	421	–	–	0.07%	75
2018 Q3	$3.72M	Hold	421	–	–	0.1%	81
2018 Q2	$3.59M	Hold	421	–	–	0.1%	86
2018 Q1	$2.17M	Hold	421	–	–	0.07%	79
2017 Q4	$2.16M	Hold	421	–	–	0.08%	69
2017 Q3	$4.55M	Hold	421	–	–	0.18%	59
2017 Q2	$3.63M	Hold	421	–	–	0.17%	57
2017 Q1	$4.04M	Hold	421	–	–	0.2%	54
2016 Q4	$4.4M	Buy	421 +175	+71%	+$2.1M	0.23%	57
2016 Q3	$3.42M	Hold	246	–	–	0.19%	48
2016 Q2	$2.67M	Hold	246	–	–	0.15%	49
2016 Q1	$3.01M	Hold	246	–	–	0.18%	52
2015 Q4	$3.17M	Hold	246	–	–	0.2%	52
2015 Q3	$3.18M	Buy	+246	New	+$3.64M	0.24%	46

Other funds holding RDHL

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Menora Mivtachim Holdings's RDHL Position: Q2 2019 in Review

Menora Mivtachim Holdings sold out of Redhill Biopharma (RDHL) in Q2 2019, closing a stake of 409 shares — an estimated $3.4M sold.

Menora Mivtachim Holdings first reported a position in RDHL in Q3 2015 and held it in 15 quarters. The position peaked at $4.55M in Q3 2017. 34 funds tracked by Wall St. Rank hold RDHL as of Q2 2019.

Menora Mivtachim Holdings reported no remaining Redhill Biopharma position as of Q2 2019 after selling out during the quarter.
Menora Mivtachim Holdings sold 409 Redhill Biopharma shares in Q2 2019, an estimated $3.4M.
Menora Mivtachim Holdings first reported a position in Redhill Biopharma in Q3 2015 and held it in 15 quarters.
Menora Mivtachim Holdings's Redhill Biopharma position peaked at $4.55M in Q3 2017.
34 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2019.

Based on Menora Mivtachim Holdings's 13F filing for Q2 2019, filed 1 Aug 2019.